Phosphoenolpyruvic acid
|
Basic information |
| Metabolite name | Phosphoenolpyruvic acid |
 | HMDB0000263 |
 |
C00074 |
 |
1005 |
| Synonyms | Phosphoenolpyruvate; |
| No. of studies | 9 |
|
Basic information |
| Metabolite name | Phosphoenolpyruvic acid |
| HMDB0000263 |
|
C00074 |
|
1005 |
| Synonyms | Phosphoenolpyruvate; |
| No. of studies | 9 |
|
Relationship between Phosphoenolpyruvic acid and depression (count: 9) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M076 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M076 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M076 | Type2 | CUMS + Anemarrhena saponins and Lilium saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1054 | Type1 | CUMS group vs. control group | Plasma | ICR mouse | Down |
| Study M1054 | Type2 | CUMS + ChaihuYujinxiang granules group vs. CUMS group | Plasma | ICR mouse | Up |
| Study M1090 | Type1 | CUMS group vs. control group | Plasma | BALb/c mouse | Up |
| Study M598 | Type1 | MS group vs. control group | Brain | Sprague-Dawley rat | Up |
| Study M664 | Type2 | CSDS + Dl-3-n-butylphthalide group vs. CSDS group | Hippocampus | C57BL/6 J mouse | Down |
| Study M712 | Type1 | depression group vs. control group | Amygdala | Cynomolgus monkey | Down |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M883 | Type1 | MDD group vs. control group | Blood | Human | Up |